We dɔktɔ tɛl yu ɔ pɔsin we yu sabi gɛt kansa, di nɛks tin we kin kam na yu maynd na fɔ du ɔpreshɔn fɔ pul di tumbu. Dat na nɔmal tin. Bɔt yu no se sɔntɛnde, bifo dis ɔpreshɔn, spɛshal tritmɛnt de we dɛn kin gi fɔ mek di tumbu smɔl, kɔntrol am, ɛn mek di ɔpreshɔn izi ɛn wok fayn? Na dat wi kin kɔl Neoadjuvant Therapy na mɛrɛsin. Tide, wi go tɔk bɔt dis, rili simpul wan, insay wan we we yu go ɔndastand.
Fɔ tɔk am simpul wan, wetin na Neoadjuvant Therapy?
Imajin se yu go rɔn wan big maratɔn. Aw i go izi if yu wam yusɛf smɔl ɛn du sɔm smɔl smɔl ɛgzampul dɛn (wɔm-ap) bifo yu bigin fɔ rɔn, pas fɔ jɔs rɔn wantɛm wantɛm? Na so i bi wit dis.
Neoadjuvant therapy na wan kayn tritmɛnt we dɛn kin gi fɔ shrink wan tumor bifo dɛn du ɔpreshɔn fɔ pul am. Yu ɔnkɔlɔjis kin kɔl am bak ``perioperative therapy'' ɔ ``induction therapy.'' Di men gol fɔ dis tritmɛnt na fɔ shrink wan big tumor so dat i go izi fɔ pul am bay ɔpreshɔn. I sɔprayz fɔ no se sɔntɛnde dis tritmɛnt kin pul di tumbu kɔmɔt kpatakpata, ɛn dis kin mek i nɔ nid fɔ du ɔpreshɔn.
Wetin na di kayn tritmɛnt we dɛn kin gi?
Bɔku men kayn tritmɛnt dɛn de we dɛn kin yuz as neoadjuvant tɛrapi. Yu dɔktɔ go disayd di tritmɛnt we go fayn fɔ yu bay tin dɛn lɛk di kayn kansa ɛn di stej we yu gɛt.
| Di we aw dɛn kin trit am | Wetin kin apin to am? |
|---|---|
| Kimotɛrapi | Dɛn kin du dis fɔ pwɛl di kansa sɛl dɛn bifo dɛn sheb ɛn di tumbu gro. |
| Ɔmon Tɛrapi | sכm kayn kεnsar (e.g. brεst, prכstat kεnsar) na כmon dεm de mek dεn kכmכt. Dis tritmɛnt de wok bay we i de blok di saplai fɔ dɛn ɔmon dɛn de ɛn stɔp di kansa fɔ mek i nɔ gro. |
| Imyunotɛrapi | Dis kin mek wi yon bɔdi in imyun sistɛm wok ɛn mek i fɛt di kansa sɛl dɛn. |
| Rɛdieshɔn Tɛrapi | Dis kin yuz raytin lɛk ɛkstrem rayt we gɛt bɔku ɛnaji fɔ pwɛl di kansa sɛl dɛn. |
Sɔntɛnde, yu mɛdikal tim kin gi yu pas wan pan dɛn tritmɛnt ya. fכ egzampl, fכ gi kεmothεrapi εn rεdyushכn tεrapi tכgeda dεn kכl am ``neoadjuvant chemoradiation.''
Dis tritmɛnt tɛm kin te fɔ sɔm wiks, sɔm mɔnt, ɔr ivin wan ia. Bɔku tɛm, dɛn kin du ɔpreshɔn insay wan mɔnt afta dɛn dɔn dɔn dis tritmɛnt.
Us kayn kansa dɛn kin yuz dis tritmɛnt fɔ?
Dis tritmɛnt we dɛn de yuz naw, dɛn de yuz am fayn fayn wan fɔ pas tɛn kayn kansa. Dis na sɔm pan di kansa dɛm wae kin kam pan pɔrsin.
Brɔst Kansa
Dis we ya impɔtant pasmak pan bɔdi kansa, mɔ:
- If di tumbu big smɔl.
- insay di kayn dεm we de spre kwik kwik wan lεk `inflammatory breast cancer`.
- fכ sכm spεsifi k tכp dεm fכ brεst kεnsar, lεk `HER2-positiv` εn `triple-negative`.
dis tritmɛnt kin alaw fɔ mek dɛn du smɔl ɔpreshɔn (lumpectomy) fɔ pul di tumbu nɔmɔ, pas fɔ mek dɛn du big ɔpreshɔn (mastectomy) we go pul di wan ol bɔdi.
Kɔlɔn Kansa
If kɔlon kansa dɔn skata (metastasized) to ɔda say dɛn, lɛk di liva, dɛn kin gi am kemotɛrapi bifo dɛn du di ɔpreshɔn.
Kansa na di Lɔng
Dɛn kin yuz kemotɛrapi ɔ kemoradyeshɔn fɔ advans nɔ-smɔl sɛl lɔng kansa.
Prɔstat Kansa
Sɔm kayn dis kansa na man dɛn kin gɛt di ɔmon we dɛn kɔl tɛstostɛron. So ɔmon tɛrapi de ridyus di wok we da ɔmon de de du ɛn i de kɔntrol di tumbu.
Kansa we de na di rεktal
I kɔmɔn fɔ gi redyushɔn tɛrapi ɛn kemotɛrapi togɛda fɔ rɛktal kansa we dɔn skata. sכmtεm, dεn kin gi kεmothεrapi fכs, dεn kin gi kεmothεrapi, insay wan mεtכd we dεn kכl ``tכtal nioadjuvant tεrapi''.
Wetin na di bɛnifit dɛm fɔ Neoadjuvant Therapy?
Bɔku bɛnifit dɛn de we pɔsin we sik kin gɛt frɔm dis tritmɛnt.
Fɔ tɔk am simpul wan, dɛn kin du dis fɔ mek di ɛnimi (kansa) wik as i pɔsibul bifo di big fɛt we dɛn kɔl ɔpreshɔn.
| Bɛnifit | Fɔ ɛksplen |
|---|---|
| Di tumbu dɛn we gɛt kansa kin smɔl | Big big tumbu dɛn kin ridyus dɛn saiz ɛn di dɔktɔ we de du ɔpreshɔn kin pul dɛn izi wan, ɛn dis kin mek di bɔdi nɔ wund we dɛn de du di ɔpreshɔn. |
| Fɔ mek i izi fɔ du ɔpreshɔn | Bikɔs di tumbu smɔl, di say we dɛn kɔt we dɛn de du di ɔpreshɔn kin smɔl. So, di tɛm fɔ wɛl kin shɔt ɛn di pen nɔ kin bɔku. |
| Fɔ mɛzhɔ aw di tritmɛnt dɔn wok fayn | Dɔktɔ dɛn kin si aw di kansa kin biev we dɛn gɛt tritmɛnt bifo dɛn du di ɔpreshɔn, ɛn dis kin ɛp dɛn fɔ disayd fɔ du di bɛst tin bɔt di tritmɛnt afta dɛn du di ɔpreshɔn. |
| Fɔ mek kansa nɔ go ɔlsay | sכmtεm, sεl dεm we de brok kכmכt frכm wan kεnsar tכmכro εn travul כlsay na di bכdi insay sכm sכm fכm dεm we dεn nכ kin no we dεn kכl ``maykrometastases.'' dεn tritmεnt dεm ya kin pwεl dεn sεl dεm we ayd insay di bכdi bak. |
| Fɔ ridyus di risk fɔ gɛt kansa bak | Risach dɔn sho se dis tritmɛnt de ridyus di risk fɔ mek sɔm kayn kansa kam bak. |
Lɛ wi no bak bɔt di bad tin dɛn we kin apin to wi.
Lɛk ɛni tritmɛnt fɔ kansa, dɛn tritmɛnt ya kin mek pɔsin gɛt sayd ɛfɛkt. Bɔt wetin dɛn bi dipen pan di kayn tritmɛnt we yu de gɛt. Sɔm pan di bad bad tin dɛn we kin apin to pɔsin na:
- Taya
- Nɔs ɛn vɔmit
- Fil fɔ it
- Rɔnbɛlɛ
- Lɔs fɔ teist na di mɔt
Bɔt nɔ wɔri. Yu dɔktɔ go tich yu bɔt di sayd ɛfɛkt dɛn we yu kin gɛt ɛn di mɛrɛsin dɛn we yu kin tek fɔ mɛn dɛn bifo yu bigin fɔ trit yu. Yu mɛdikal tim go ɛp yu bak fɔ manej dɛn sik ya to bɔku bɔku wan tru palliativ kia.
Ustɛm yu nid fɔ go to dɔktɔ?
We yu de gɛt dis tritmɛnt, yu mɛdikal tim go de wach yu gud gud wan. Bɔt if yu gɛt ɛni prɔblɛm, nɔ de te fɔ ripɔt am.
If ɛni wan pan dɛn tin ya apin, kɔl yu dɔktɔ wantɛm wantɛm:
- If di sayd ɛfɛkt dɛn wɔs pas aw yu bin de tink: Fɔ ɛgzampul, if yu nɔ ebul fɔ kɔntrol di nɔys ivin afta yu dɔn tek mɛrɛsin, ɛn yu nɔ kin fil fayn ɔl di de.
- If yu notis nyu chenj na yu bɔdi: If yu gɛt ɛni nyu sayn we de sho se di kansa de wɔs.
Wetin na di difrɛns bitwin Nioadjuvant ɛn Adjuvant Tɛrapi?
Dɛn tu wɔd ya kin mek pɔsin kɔnfyus smɔl, bɔt di difrɛns rili simpul.
- Neoadjuvant Therapy: Tritmɛnt we dɛn kin gi bifo dɛn du ɔpreshɔn (lɛk fɔ wam-ap bifo dɛn rɔn maraton).
- Adjuvant Therapy: Na tritmɛnt we dɛn kin gi afta dɛn dɔn du di ɔpreshɔn. Dɛn kin du dis fɔ kil ɛni kansa sɛl we kin lɛf na di bɔdi afta dɛn dɔn du di ɔpreshɔn ɛn mek di kansa nɔ kam bak. (Lɛk we pɔsin kin kol-dɔwn afta yu dɔn rɔn maratɔn).
Neoadjuvant therapy nɔto tritmɛnt opshɔn fɔ ɔlman we gɛt kansa. Bɔt i go bi se i go fayn fɔ yu, i go bi se i go fayn fɔ yu, i go bi se i go fayn fɔ yu. So, tɔk opin wan bɔt dis wit yu dɔktɔ. Aks ɔl yu kwɛstyɔn ɛn gɛt gud ɔndastandin bɔt yu tritmɛnt joyn.
Mɛsej we dɛn kin kɛr go na os
- Neoadjuvant therapy na tritmɛnt we dɛn kin gi bifo dɛn du ɔpreshɔn fɔ shrink ɔ pwɛl wan kansa tumor.
- Dis kin mek di ɔpreshɔn izi, sef, ɛn i kin wok fayn. Sɔntɛnde, i nɔ kin nid fɔ du ɔpreshɔn.
- Dɛn kin yuz difrɛn kayn tritmɛnt lɛk kemotɛrapi, redyushɔn tɛrapi, ɛn ɔmon tɛrapi ɔnda dis.
- Dis tritmɛnt de mek dɔktɔ dɛn ebul bak fɔ no di tritmɛnt we go wok fayn fɔ wan patikyula kansa.
- Yu mɛdikal tim go ɛp yu fɔ kɔntrol di sayd ɛfɛkt dɛm wae yu de trit yu, so nɔr frayd fɔ tɔk to dɛm bɔt ɛnitin wae de mɔna yu.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt